SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10642	Companies
226308	Keywords
154798	Articles
119785	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/15/2025 at 07:05, 6 months 11 days ago

Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la sclérose en plaques primaire progressive
Sanofi annonce l'arrêt du développement du tolebrutinib dans la sclérose en plaques primaire progressive après l'étude de phase 3 PERSEUS. Profil de sécurité cohérent, analyse détaillée à venir

Sclérose En Plaques Sanofi Étude Tolebrutinib PERSEUS
PRESS RELEASE

published on 12/15/2025 at 07:05, 6 months 11 days ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 6 months 11 days ago

Le dépôt de la demande d'autorisation de mise sur le marché du tolebrutinib de Sanofi est retardé.

FDA Sclérose En Plaques Sanofi Tolebrutinib Retard Réglementaire
BRIEF

published on 12/15/2025 at 07:05, 6 months 11 days ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 6 months 11 days ago

Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolébrutinib dans la sclérose en plaques secondaire progressive non-récurrente
Sanofi retarde la soumission réglementaire du tolébrutinib pour la SEPSPnr, attend des orientations supplémentaires de la FDA au premier trimestre 2026

FDA Sclérose En Plaques Sanofi Tolebrutinib SEPSPnr
PRESS RELEASE

published on 12/15/2025 at 07:00, 6 months 11 days ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 6 months 15 days ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi
BRIEF

published on 12/11/2025 at 07:05, 6 months 15 days ago

Sanofi obtient l'approbation en Chine pour Qfitlia et Cablivi

Chine Sanofi Maladies Rares Qfitlia Cablivi
BRIEF

published on 12/11/2025 at 07:05, 6 months 15 days ago

Sanofi's Breakthrough in China with Qfitlia and Cablivi Approvals

Sanofi Rare Diseases Qfitlia Cablivi China Approvals
BRIEF

published on 12/11/2025 at 07:05, 6 months 15 days ago

Percée majeure de Sanofi en Chine avec les approbations de Qfitlia et Cablivi

Sanofi Maladies Rares Qfitlia Cablivi Approbations De La Chine

Accesswire

Published on 06/26/2026 at 01:40, 5 hours 55 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 5 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 5 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 3 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 5 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 04:20, 3 hours 15 minutes ago

VARON Helps Travelers Breathe Easy This Summer With Portable Oxygen Concentrators Built for Mobility
Published on 06/26/2026 at 02:05, 5 hours 30 minutes ago

VARON Marks "Love Your Lungs Week" With a Call to Prioritize Summer Respiratory Health Across Europe
Published on 06/25/2026 at 22:40, 8 hours 55 minutes ago

DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Published on 06/25/2026 at 19:00, 12 hours 34 minutes ago

EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 12 hours 36 minutes ago

OHB Digital Connect completes upgrade of military ground stations

Les Echos

Published on 06/26/2026 at 07:00, 35 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 35 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 12 hours 50 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 5 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 13 hours 45 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE